Lv2
140 积分 2025-03-28 加入
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
8小时前
已完结
Structural and functional insights into CD3 bispecific antibodies targeting DLL3 in cancer immunotherapy
13天前
已完结
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
25天前
已完结
An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors
25天前
已完结
Process optimization of mRNA purification for vaccines and therapeutic applications
4个月前
已关闭
CureVac COVID vaccine let-down spotlights mRNA design challenges
7个月前
已完结
The structure of the llama heavy chain constant genes reveals a mechanism for heavy-chain antibody formation
8个月前
已完结
Development of an 18F-labeled anti-human CD8 VHH for same-day immunoPET imaging
8个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
8个月前
已完结
Emerging trends in the characterization of oligonucleotide diastereomers
10个月前
已完结
皖公网安备34019202002308
